Pharmaceutical Technology

SEPTEMBER 11, 2023

With many biopharma companies outsourcing for manufacturing support, how can your organisation outpace the competition?

Competition 59

Competition Pharmaceutical manufacturing Manufacturing Biopharma 59

Pharmaceutical Technology

JULY 29, 2022

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.

Biopharma 59

Biopharma Manufacturing Government Engineering 59

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009.

Pharma 104

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 104

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP.

Manufacturing 104

Manufacturing Medicine Government Pharmaceutical manufacturing 104

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing.

Manufacturing 73

Manufacturing Pharmaceutical Healthcare Healthcare 73